26 related articles for article (PubMed ID: 11820293)
1. Development and Validation of a UPLC-MS/MS Method for Therapeutic Drug Monitoring, Pharmacokinetic and Stability Studies of First-Line Antituberculosis Drugs in Urine.
Abouzid M; Kosicka-Noworzyń K; Karaźniewicz-Łada M; Rao P; Modi N; Xie YL; Heysell SK; Główka A; Kagan L
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257250
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of a Simple High-Pressure Liquid Chromatography-Ultraviolet Detection Method for Simultaneous Quantitation of First-Line Anti-Tuberculosis Drugs in Formulations of Fixed-Dose Combination.
Vilvamani S; Mahalingam S; Nhavilthodi S; Murugesan D; Jeyakumar SM
J Chromatogr Sci; 2024 May; ():. PubMed ID: 38717231
[TBL] [Abstract][Full Text] [Related]
3. A validated liquid chromatography-tandem mass spectrometry assay for the analysis of isoniazid and its metabolite acetyl-isoniazid in urine.
Maputla SP; Van Dalen W; Joubert A; Norman J; Castel S; van der Merwe M; Wiesner L
J Mass Spectrom Adv Clin Lab; 2024 Apr; 32():11-17. PubMed ID: 38356778
[TBL] [Abstract][Full Text] [Related]
4. Optimization and Validation of a Chromatographic Method for the Quantification of Isoniazid in Urine of Tuberculosis Patients According to the European Medicines Agency Guideline.
Mishra P; Albiol-Chiva J; Bose D; Durgbanshi A; Peris-Vicente J; Carda-Broch S; Esteve-Romero J
Antibiotics (Basel); 2018 Dec; 7(4):. PubMed ID: 30545003
[TBL] [Abstract][Full Text] [Related]
5. A Simple and Sensitive UPLC-UV Method for Simultaneous Determination of Isoniazid, Pyrazinamide, and Rifampicin in Human Plasma and Its Application in Therapeutic Drug Monitoring.
Jiang Z; Huang L; Zhang L; Yu Q; Lin Y; Fei H; Shen H; Huang H
Front Mol Biosci; 2022; 9():873311. PubMed ID: 35573738
[TBL] [Abstract][Full Text] [Related]
6. Real-life isoniazid and rifampicin plasma concentrations in children: a tool for therapeutic drug monitoring of tuberculosis.
Tersigni C; Boiardi G; Tofani L; Venturini E; Montagnani C; Bortone B; Bianchi L; Chiappini E; Cassetta MI; Fallani S; Novelli A; Galli L
BMC Infect Dis; 2021 Oct; 21(1):1087. PubMed ID: 34674665
[TBL] [Abstract][Full Text] [Related]
7. Simultaneous determination of first-line anti-tuberculosis drugs and one metabolite of isoniazid by liquid chromatography/tandem mass spectrometry in patients with human immunodeficiency virus-tuberculosis coinfection.
Xing Y; Yin L; Le X; Chen J; Zhang L; Li Y; Lu H; Zhang L
Heliyon; 2021 Jul; 7(7):e07532. PubMed ID: 34296020
[TBL] [Abstract][Full Text] [Related]
8. Prevention of isoniazid toxicity by NAT2 genotyping in Senegalese tuberculosis patients.
Toure A; Cabral M; Niang A; Diop C; Garat A; Humbert L; Fall M; Diouf A; Broly F; Lhermitte M; Allorge D
Toxicol Rep; 2016; 3():826-831. PubMed ID: 28959610
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic drug monitoring of three antiepileptic drugs - Back on twenty years of experience].
Serragui S; Zalagh F; Tanani DS; Ouammi L; Moussa LA; Badrane N; Bencheikh RS
Pan Afr Med J; 2016; 25():10. PubMed ID: 28154702
[TBL] [Abstract][Full Text] [Related]
10. Rifampicin and isoniazid plasma concentrations in relation to adverse reactions in tuberculosis patients: a retrospective analysis.
Aït Moussa L; El Bouazzi O; Serragui S; Soussi Tanani D; Soulaymani A; Soulaymani R
Ther Adv Drug Saf; 2016 Dec; 7(6):239-247. PubMed ID: 27904742
[TBL] [Abstract][Full Text] [Related]
11. Correlation of N-acetyltransferase 2 genotype with isoniazid acetylation in Polish tuberculosis patients.
Zabost A; Brzezińska S; Kozińska M; Błachnio M; Jagodziński J; Zwolska Z; Augustynowicz-Kopeć E
Biomed Res Int; 2013; 2013():853602. PubMed ID: 24383060
[TBL] [Abstract][Full Text] [Related]
12. Effect of rifampicin & isoniazid on the steady state pharmacokinetics of moxifloxacin.
Ramachandran G; Hemanth Kumar AK; Srinivasan R; Geetharani A; Sugirda P; Nandhakumar B; Nandini R; Tharani CB
Indian J Med Res; 2012 Dec; 136(6):979-84. PubMed ID: 23391793
[TBL] [Abstract][Full Text] [Related]
13. Solid-phase extraction and HPTLC determination of isoniazid and acetylisoniazid in serum. Comparison with HPLC.
Guermouche S; Guermouche MH
J Chromatogr Sci; 2004; 42(5):250-3. PubMed ID: 15189597
[TBL] [Abstract][Full Text] [Related]
14. Simultaneous determination of isoniazid, pyrazinamide, rifampicin and acetylisoniazid in human plasma by high-performance liquid chromatography.
Zhou Z; Chen L; Liu P; Shen M; Zou F
Anal Sci; 2010; 26(11):1133-8. PubMed ID: 21079341
[TBL] [Abstract][Full Text] [Related]
15. Rapid, specific and sensitive method for isoniazid determination in serum.
Sadeg N; Pertat N; Dutertre H; Dumontet M
J Chromatogr B Biomed Appl; 1996 Jan; 675(1):113-7. PubMed ID: 8634752
[TBL] [Abstract][Full Text] [Related]
16. Determination of isoniazid methanesulphonate and its metabolites in rabbit blood by high-performance liquid chromatography.
Hsu KY; Ho Y
J Chromatogr; 1989 Sep; 493(2):305-12. PubMed ID: 2584297
[TBL] [Abstract][Full Text] [Related]
17. Development and validation of liquid chromatography tandem mass spectrometry method for simultaneous quantification of first line tuberculosis drugs and metabolites in human plasma and its application in clinical study.
Hee KH; Seo JJ; Lee LS
J Pharm Biomed Anal; 2015 Jan; 102():253-60. PubMed ID: 25459921
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic isoniazid monitoring using a simple high-performance liquid chromatographic method with ultraviolet detection.
Moussa LA; Khassouani CE; Soulaymani R; Jana M; Cassanas G; Alric R; Hüe B
J Chromatogr B Analyt Technol Biomed Life Sci; 2002 Jan; 766(1):181-7. PubMed ID: 11820293
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
